NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1134124159 M.D.
Verify on CMS → Daniel Rosler, M.D.
Rheumatology Physician in Milwaukee, Wisconsin.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 334 beneficiaries · Rheumatology Physician avg: 2K
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$125
1 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Daniel Rosler, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 2,834 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥88th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Daniel Rosler, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1134124159), first enumerated 06/16/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,834 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$125 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1134124159 · Rheumatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1134124159
- ENUM-LEGACY 2005
- TAX-MID 6K Rheumatology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 2,834
- BOOK-THIN 118 in Wisconsin
- PHOTO-ENUM Farah Ashraf · 2005
Daniel Rosler, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,834 ≥ 88th percentile 88% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Daniel Rosler, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Rosler, M.D.?
CMS neutral score, not measuredPrimary specialty
Rheumatology Physician
Medicare Part D claims
2,834 38% vs specialty avg
MIPS final score
75/100
Specialty distribution in Wisconsin
How Rheumatology Physician compares to other specialties among Wisconsin providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1134124159 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/16/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Rosler, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$125
Largest payer
UCB, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,834
Total Claims
$3.7M
Total Drug Cost
334
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,198.733
- Total Day Supply
- 153,303
- Generic Drug Cost
- $59K
- Opioid Claims
- 111 (3.9% rate)
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.71
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 41, 65-74: 151, 75-84: 105, 85+: 37
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Daniel Rosler, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Methotrexate
Methotrexate
483 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
429 claims
- Prednisone
Prednisone
321 claims
- Humira(Cf) Pen 107
Humira(Cf) Pen
107 claims
- Gabapentin 74
Gabapentin
74 claims
- Xeljanz Xr 74
Xeljanz Xr
74 claims
- Leucovorin Calcium 67
Leucovorin Calcium
67 claims
- Folic Acid 66
Folic Acid
66 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 483 |
| Hydroxychloroquine Sulfate | 429 |
| Prednisone | 321 |
| Humira(Cf) Pen Adalimumab | 107 |
| Gabapentin | 74 |
| Xeljanz Xr Tofacitinib Citrate | 74 |
| Leucovorin Calcium | 67 |
| Folic Acid | 66 |
| Mycophenolate Mofetil | 65 |
| Allopurinol | 57 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Daniel Rosler, M.D. fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Daniel Rosler, M.D.'s 2,834 claims are above the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rosler, both outside Wisconsin so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as Rosler.
One of 118 Rheumatology Physician providers enrolled in Wisconsin, 5 are shown here.
Dr. Safiyya Abdulkadir
MD
Madison, WI
Dr. Gina Adel
MD
Eau Claire, WI
Dr. Suraiya Afroz
D.O.
Manitowoc, WI
Dr. John Albert
MD
Glendale, WI
Dr. Isabelle Amigues
MD
Green Bay, WI
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Daniel Rosler, M.D.'s specialty? ▼
Daniel Rosler, M.D. specializes in Rheumatology Physician and practices in Milwaukee, Wisconsin. Credentials: M.D..
How much does Daniel Rosler, M.D. prescribe under Medicare Part D? ▼
In 2024, Daniel Rosler, M.D. wrote 2,834 Medicare Part D claims totaling $3.7M in drug costs for 334 beneficiaries.
What is Daniel Rosler, M.D.'s Medicare quality score? ▼
Daniel Rosler, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Daniel Rosler, M.D. located? ▼
Daniel Rosler, M.D. is located at 2901 W KINNICKINNIC RIVER PKWY, Milwaukee, WI, 53215. Phone: (414) 672-8550.
What is Daniel Rosler, M.D.'s NPI number? ▼
Daniel Rosler, M.D.'s National Provider Identifier (NPI) is 1134124159, issued on 06/16/2005.
Does Daniel Rosler, M.D. prescribe opioids? ▼
Yes, Daniel Rosler, M.D. had 111 opioid claims in 2024 with an opioid prescribing rate of 3.9%.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Daniel Rosler, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Daniel Rosler, M.D.'s most frequently prescribed drugs include Methotrexate, Hydroxychloroquine Sulfate, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Rosler, M.D. accept Medicare? ▼
Daniel Rosler, M.D. appears in CMS Medicare data with 2,834 Part D claims and 334 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Rosler, M.D.'s credentials? ▼
Daniel Rosler, M.D.'s NPI is 1134124159 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.